These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6438535)

  • 41. Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts.
    Karasuyama H; Rolink A; Melchers F
    J Exp Med; 1988 Apr; 167(4):1377-90. PubMed ID: 3128631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Supernatant from a cloned helper T cell stimulates resting B cells to express transferrin and IL-2 receptors.
    Diu A; Leclercq L; Dautry-Varsat A; Theze J
    Cell Immunol; 1987 Jul; 107(2):471-8. PubMed ID: 2954656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transient expression of interleukin 2 receptors. Consequences for T cell growth.
    Cantrell DA; Smith KA
    J Exp Med; 1983 Dec; 158(6):1895-911. PubMed ID: 6606011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human T cell leukemia/lymphoma virus I infection and subsequent cloning of normal human B cells. Direct responsiveness of cloned cells to recombinant interleukin 2 by differentiation in the absence of enhanced proliferation.
    Tomita S; Ambrus JL; Volkman DJ; Longo DL; Mitsuya H; Reitz MS; Fauci AS
    J Exp Med; 1985 Jul; 162(1):393-8. PubMed ID: 2989412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses.
    Malek TR; Robb RJ; Shevach EM
    J Immunol; 1983 Feb; 130(2):747-55. PubMed ID: 6184403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
    Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N
    J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T cell-derived B cell growth and differentiation factors.
    Romagnani S
    Ric Clin Lab; 1987; 17(3):181-97. PubMed ID: 3313664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Aug; 139(4):1005-13. PubMed ID: 3112218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B.
    Hamel ME; Eynon EE; Savelkoul HF; van Oudenaren A; Kruisbeek AM
    Int Immunol; 1995 Jul; 7(7):1065-77. PubMed ID: 8527404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and the functional role of a p70/75 interleukin 2-binding molecule in human B cell.
    Saiki O; Tanaka T; Doi S; Kishimoto S
    J Immunol; 1988 Feb; 140(3):853-8. PubMed ID: 2828472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential effects of interleukin 2 vs B cell growth factor on human B cells.
    Nakagawa T; Nakagawa N; Ambrus JL; Fauci AS
    J Immunol; 1988 Jan; 140(2):465-9. PubMed ID: 2447179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
    Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the human receptor for T-cell growth factor.
    Leonard WJ; Depper JM; Robb RJ; Waldmann TA; Greene WC
    Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6957-61. PubMed ID: 6417659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety.
    Ayanlar-Batuman O; Ebert E; Hauptman SP
    Blood; 1986 Feb; 67(2):279-84. PubMed ID: 2935203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of the expression of Tac antigen (T-cell growth factor response) on human thymocytes.
    Yeh NH; Dipre M; Reem GH
    Thymus; 1984; 6(4):255-61. PubMed ID: 6437022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural and functional characterization of IL 2 receptors on activated human B cells.
    Boyd AW; Fisher DC; Fox DA; Schlossman SF; Nadler LM
    J Immunol; 1985 Apr; 134(4):2387-92. PubMed ID: 3919091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin 2 receptor dysfunction in mice undergoing a graft-vs-host reaction.
    Joseph LJ; Iwasaki T; Malek TR; Shearer GM
    J Immunol; 1985 Sep; 135(3):1846-50. PubMed ID: 3926888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells.
    Tohma S; Lipsky PE
    J Immunol; 1991 Apr; 146(8):2544-52. PubMed ID: 1707911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of interleukin 2 receptiveness and proliferation in resting peripheral T cells by monoclonal anti-CD3 (T3) antibodies does not require the presence of macrophages.
    Stingl LA; Sinska A; Landesmann U; Smolen JS
    Clin Exp Immunol; 1987 Apr; 68(1):146-55. PubMed ID: 3115639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.